| HOME >> MEDICINE >> TECHNOLOGY |
Receives CE mark approval 51
Terumo Introduces Its Drug-Eluting Stent in Germany and Marks
Its European Entry 52
Tryton Medical's Side-Branch Stent Achieves CE Mark Approval 52
CV Therapeutics Offers its Stent Coating Technology to
Medlogics Device Corporation 52
Abbott's 2.25mm-Sized XIENCE™ V Drug Eluting Stent receives CE
Mark of Approval 52
Biosensors Receives CE Mark Approval for BioMatrix® Stent System 53
Nfocus Neuromedical's CardioVasc™ Stent-Graft and Delivery
System Receives CE Mark Approval 53
11. FOCUS ON SELECT GLOBAL PLAYERS 54
Angiotech Pharmaceuticals (Canada) 54
Abbott Vascular (USA) 54
Biosensors International (USA) 54
Boston Scientific Corp. (USA) 55
Cordis Corporation (JNJ) - (USA) 55
Medtronic, Inc. (USA) 56
Medtronic Cardiovascular, Inc. (USA) 56
OrbusNeich (Hong Kong) 56
Terumo Europe N.V. (Belgium) 56
12. GLOBAL MARKET PERSPECTIVE 57
Table 4: World Recent Past, Current & Future Analysis for
Coronary Stents By Geographic Region - US, Japan, Europe,
Asia-Pacific (Excluding Japan) and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
years 2009 through 2017 (includes corresponding Graph/Chart) 57
Table 5: World Recent Past, Current & Future Analysis for
Coronary Stents by Geographic Region - US, Japan, Europe,
Asia-Pacific (Excluding Japan) and Rest of World Markets
Independently Analyzed with Annual Sales in Thousand Units for
years 2009 through 2017 (includes corresponding Graph/Chart) 58
Table 6: World Historic Review for Coronary Stents by
Geographic Region - US, Japan, Europe, Asia-Pacific (Excluding
Japan) and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2003 thr
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |